Improving data analysis for osteoarthritis research
Official title: Core D: Analysis Core
Funded at Boston University Medical Campus · NIH-11056746 · Data updated 2026-11-12
This study is working to improve how we analyze data about osteoarthritis, so that researchers can better understand and treat the condition, ultimately helping patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | June 1, 2023 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $1,157,872 |
| NIH project number | 5U19AG076471-03 |
| Project ID | NIH-11056746 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with osteoarthritis or those at risk of developing the condition.
✕Less likely to help
Patients with conditions unrelated to osteoarthritis may not receive any benefit from this research.
What this research studies
This research focuses on enhancing the analysis of data related to osteoarthritis (OA) through a dedicated Analysis Core. It aims to provide high-quality analytic services, ensuring that the methods used in OA studies are rigorous and reproducible. The core will support three major scientific projects by reviewing analysis plans, developing operational procedures, and conducting sophisticated statistical analyses. Patients can benefit from improved understanding and treatment of OA as a result of these enhanced research efforts.
Why it matters
Potential benefit: If successful, this research could lead to better treatment strategies and outcomes for patients suffering from osteoarthritis.
How similar studies have gone: Previous research in osteoarthritis has shown that advanced data analysis techniques can significantly enhance understanding and treatment outcomes.
Where this research is happening
-
Boston University Medical Campus
Boston, United States Active
Researchers
- Principal investigator: Lavalley, Michael Paul — Boston University Medical Campus
- Study coordinator: Lavalley, Michael Paul
Related research
Other NIH-funded projects on the same topics.
-
Creating a detailed map of early lung cancer changes
This study is looking at early changes in lung tissue that can lead to cancer, specifically focusing on common types of lung cancer, and it's for patients who want to help researchers understand these changes better so they can improve early detection and treatment.
-
Telomere trouble in ALT cancers: what causes damage and how it happens
Researchers are studying why some cancer cells use ALT to lengthen telomeres and how replication stress damages telomeres, aiming to uncover key processes that could be targeted in patients.
-
IL-6 signaling, lung injury, and post-TB lung disease in TB/HIV
This grant tests how a specific immune signal (IL-6) relates to lung damage after tuberculosis in people with and without HIV, aiming to understand who is at risk for lasting lung problems.
-
IL-6 signaling and lung injury after TB and HIV co-infection
This project looks at how a common immune signal called IL-6 relates to lung injury after TB treatment, especially in people who also have HIV.
-
LEAD Africa: advancing Alzheimer’s research across Africa
A new project aims to build Alzheimer’s disease research capabilities in Africa to improve understanding and care for people with dementia.
-
Leading AD and related dementias research in Africa
A multi-country effort aims to build Africa’s capacity to study Alzheimer’s disease and related dementias using scalable, low-cost methods.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.